Pharmacological characterization of a novel, orally active, nonpeptide bradykinin B2 receptor antagonist, FR167344

European Journal of Pharmacology

Volumn 333, Issue 1, 1997, Pages 79-86

  Inamura, Noriaki ^a   Asano, Masayuki ^a   Hatori, Chie ^a   Sawai, Hiroe ^a   Jiro Hirosumi, ^a   Fujiwara, Tatsujiro ^a   Kayakiri, Hiroshi ^a   Satoh, Shigeki ^a   Abe, Yoshito ^a   Inoue, Takayuki ^a   Sawada, Yuki ^a   Oku, Teruo ^a   Nakahara, Kunio ^a  

^a Exploratory Research Laboratories   (Japan)

Author keywords

Bradykini B2 receptor; Bradykinin; Bradykinin receptor antagonist; FR167344; FR172357; Orally active

Indexed keywords

3 BROMO 8 [2,6 DICHLORO 3 [N [4 (N,N DIMETHYLCARBAMOYL)CINNAMIDOACETYL] N METHYLAMINO]BENZYLOXY] 2 METHYLIMIDAZO[1,2 A]PYRIDINE; BRADYKININ; BRADYKININ ANTAGONIST; BRADYKININ B2 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHOSPASM; CONTROLLED STUDY; DRUG RECEPTOR BINDING; GUINEA PIG; HUMAN; HUMAN CELL; ILEUM; IN VITRO STUDY; LUNG FIBROBLAST; MALE; NONHUMAN; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; UTERUS;

EID: 0030768697     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01100-X     Document Type: Article

References (27)

1. 2 receptor. Mol. Pharmacol., in press.
2. Asano M., Inamura N., Nakahara K., Nagayoshi A., Isono T., Hamada K., Oku T., Notsu Y., Kohsaka M., Ono T. A 5-lipoxygenase inhibitor, FR110302, suppresses airway hyperresponsiveness and lung eosinophilia induced by sephadex particles in rats. Agents Actions. 36:1992;215-221.
3. Barnes P.J., Chung F., Page C.P. Inflammatory mediators and asthma. Pharmacol. Rev. 40:1988;49-83.
4. Bhoola K.D., Figueroa C.D., Worthy K. Bioregulation of kinins: Kallikreins, kininogens, and kininases. Pharmacol. Rev. 44:1992;1-80.
5. 2. Proc. Natl. Acad. Sci. USA. 85:1987;6374-6378.
6. Burch R.M., Farmer S.G., Steranka L.R. Bradykinin receptor antagonists. Med. Res. Rev. 10:1990;237-269.
7. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:1973;3099-3108.
8. Cheronis J.C., Whalley E.T., Nguyen K.T., Eubanks S.R., Allen L.G., Duggan M.J., Loy S.D., Bonham K.A., Blodgett J.K. A new class of bradykinin antagonists: Synthesis and in vitro activity of bissuccinimidoalkane peptide dimers. J. Med. Chem. 35:1992;1563-1572.
9. Christiansen S.C., Proud D., Cochrane C.G. Detection of tissue kallikrein in bronchoalveolar lavage fluid of asthmatic subjects. J. Clin. Invest. 79:1987;188-197.
10. Farmer S.G. Role of kinins in airway diseases. Immunopharmacology. 22:1991;1-20.
11. Fuller R.W., Dixon C.M.S., Cuss F.M.C., Barnes P.J. Bradykinin-induced bronchoconstriction in humans. Am. Rev. Respir. Dis. 135:1987;176-180.
12. Hess J.F., Borkowski J.A., Young G.S., Strader C.D., Ransom R.W. Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. Biochem. Biophys. Res. Commun. 184:1992;260-268.
13. Hock F.J., Wirth K., Albus U., Linz W., Gerhards H.J., Wiemer G., Henke S., Breipohl G., König W., Knolle J., Schölkens B.A. Hoe 140 a new potent and long acting bradykinin-antagonist: In vitro studies. Br. J. Pharmacol. 102:1991;769-773.
14. Ishizaka T., Iwata M., Ishizaka K. Release of histamine and arachidonate from mouse mast cells induced by glycosylation-enhancing factor and bradykinin. J. Immunol. 134:1985;1880-1887.
15. Konzett H., Rössler R. Versuchsanordnung zu untersuchungen an der bronchialmuskulatur. Naunyn-Schmiedeberg's Arch. Exp. Path. Pharmak. 195:1940;71-74.
16. Manning D.C., Vavrek R., Stewart J.M., Snyder S.H. Two bradykinin binding sites with picomolar affinities. J. Pharmacol. Exp. Ther. 237:1986;504-512.
17. 1 bradykinin receptor. J. Biol. Chem. 269:1994;21583-21586.
18. Proud D., Kaplan A. Kinin formation: Mechanisms and role in inflammatory disorders. Ann. Rev. Immunol. 6:1988;49-83.
19. Regoli D., Barabé J. Pharmacology of bradykinin and related peptides. Pharmacol. Rev. 32:1980;1-46.
20. Regoli D., Barabé J., Park W.K. Receptors for bradykinin in rabbit aorta. Can. J. Physiol. Pharmacol. 55:1977;855-867.
21. 8]bradykinin). Eur. J. Pharmacol. 210:1992;115-120.
22. Saria A., Martling C.R., Yan Z., Theodorsson-Norheim E., Gamse R., Lundberg J.M. Release of multiple tachykinins from capsaicin-sensitive sensory nerves in the lung by bradykinin, histamine, dimethylphenyl piperazinium, and vagal nerve stimulation. Am. Rev. Respir. Dis. 137:1988;1330-1335.
23. 2 receptor antagonist. Proc. Natl. Acad. Sci. USA. 91:1994;4693-4697.
24. 2, a new scale for the measurement of drug antagonism. Br. J. Pharmacol. 2:1947;186-206.
25. Stewart J.M. Bradykinin antagonists: Development and applications. Biopolymers. 37:1995;143-155.
26. Vavrek R., Stewart J.M. Competitive antagonists of bradykinin. Peptides. 6:1985;161-164.
27. Wirth K., Hock F.J., Albus U., Linz W., Alpermann H.G., Anagnostopoulos H., Henk S., Breipohl G., König W., Knolle J., Schölkens B.A. Hoe 140 a new potent and long acting bradykinin-antagonist: In vivo studies. Br. J. Pharmacol. 102:1991;774-777.